Literature DB >> 8085590

Comparative toxicity of mitomycin C and 5-fluorouracil in vitro.

S Smith1, P A D'Amore, E B Dreyer.   

Abstract

The adjunctive use of antimetabolites has revolutionized surgical procedures to correct glaucoma in the past decade. Although much is known about the in vitro and in vivo actions of 5-fluorouracil and mitomycin C, their use in the eye has raised new questions about cellular toxicity. For example, filtering blebs after a surgical procedure supplemented with mitomycin C are relatively avascular in comparison with those seen with 5-fluorouracil supplementation. We investigated the effect of 5-fluorouracil and mitomycin C on cultured capillary endothelial cells and fibroblasts. The viability and morphologic characteristics of 3T3 fibroblasts and capillary endothelial cells were studied in light of increasing doses of 5-fluorouracil and mitomycin. Both cell types showed similar sensitivity to mitomycin C. However, fibroblasts were far more sensitive to 5-fluorouracil than were the cultured microvascular endothelial cells. Thus 5-fluorouracil appears to be toxic to fibroblasts while sparing vascular endothelial cells, whereas mitomycin C is cytotoxic for both cell types.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8085590     DOI: 10.1016/s0002-9394(14)72957-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

1.  Trypan blue identifies antimetabolite treatment area in trabeculectomy.

Authors:  P R Healey; J G Crowston
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Trabeculectomy augmented with mitomycin C application under the scleral flap.

Authors:  S Beatty; T Potamitis; S Kheterpal; E C O'Neill
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

3.  Combined trabeculotomy and trabeculectomy: outcome for primary congenital glaucoma in a West African population.

Authors:  V A Essuman; I Z Braimah; T A Ndanu; C T Ntim-Amponsah
Journal:  Eye (Lond)       Date:  2010-11-05       Impact factor: 3.775

4.  5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium.

Authors:  C O Bekibele; T F Sarimiye; A Ogundipe; S Olaniyan
Journal:  Eye (Lond)       Date:  2016-03-18       Impact factor: 3.775

5.  Tocotrienol inhibits proliferation of human Tenon's fibroblasts in vitro: a comparative study with vitamin E forms and mitomycin C.

Authors:  Alexander Meyenberg; David Goldblum; Jean-Marc Zingg; Angelo Azzi; Kalanithi Nesaretnam; Monika Kilchenmann; Beatrice E Frueh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-21       Impact factor: 3.117

6.  Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation.

Authors:  Li-Fong Seet; Wing Sum Lee; Roseline Su; Sharon N Finger; Jonathan G Crowston; Tina T Wong
Journal:  Mol Med       Date:  2011-01-11       Impact factor: 6.354

7.  Antifibrotic effects of tocotrienols on human Tenon's fibroblasts.

Authors:  Christoph Tappeiner; Alexander Meyenberg; David Goldblum; Daniel Mojon; Jean-Marc Zingg; Kalanithi Nesaretnam; Monika Kilchenmann; Beatrice E Frueh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-14       Impact factor: 3.117

Review 8.  Mitomycin: clinical applications in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

9.  [Long-term results after trabeculectomy with 5-fluorouracil].

Authors:  A Koutsonas; A Remky; N Plange
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

10.  Comparison of standard and low dose intraoperative mitomycin C in prevention of corneal hazeafter photorefractive keratectomy.

Authors:  Hassan Razmjoo; Mohammad Reza Kooshanmehr; Alireza Peyman; Zahra Kor; Erfan Mohammadesmaeil
Journal:  Int J Prev Med       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.